2 min read
Operationalizing Adaptive Design for FDA's One-Trial Era
Operationalizing Adaptive Design for FDA's One-Trial Era
October 20, 2026 : 11:00 AM ET
On February 18, 2026, the FDA...
1 min read
Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to accelerate trial success in complex neurological and psychiatric conditions. Our collaborative efforts have supported successful marketing applications, breakthrough therapy designations, and innovative trial solutions across rare and ultra-rare neurological disorders.
With 250+ clinical trials and projects completed in the past 10 years, we bring proven expertise to the most challenging neuroscience therapeutic areas. Our diverse trial experience includes drug, biologic, and diagnostic trials—including pediatric gene therapy, stroke cell therapy, and psychiatric NDA submissions, with more than 30% focused on rare or ultra-rare neurological diseases.
In our neurology/psychiatry portfolio, learn how our team has helped sponsors to solve challenges across numerous areas including:
-
Pediatric gene therapy advancement
-
Strategic NDA/BLA submission support
-
Complex stroke therapy logistics
-
Rare disease trial management
-
Regulatory approval navigation (FDA, EMA, and regional agencies)
-
International family coordination
Download our complete fact sheet "Accelerate Neurology/Psychiatry Trial Success with Expert Guidance"
